Skip to main content

Abbott Northwestern Hospital

Prescription Assistance Fund: A lifeline supported through philanthropy

A physician giving a prescription to a patient

Give now to support the Abbott Northwestern Hospital Foundation.

In 2012, the Abbott Northwestern Hospital Foundation granted more than $115,000 to three programs that assist patients who lack the financial ability and resources to pay for prescriptions.

A lifeline for caregivers and patients alike, the programs improve outcomes by ensuring that patients receive the medications they need.

The programs include:

  • Abbott Northwestern Hospital’s Prescription Assistance Program, which provides a 30-day supply of prescription medications to patients who are underinsured or uninsured.

    “Patients are so thankful,” said Vicki Swan, LICSW, manager of Social Services. “These patients are already in a stressful situation, and need these medications, or they end up back in the hospital.”

    Last year, the program supplied 155 patients with more than $34,000 in prescription medications as they were discharged from the hospital.

  • The ED Cares Prescription Assistance Grant, which offers funds to eligible Emergency Department patients and is funded through gifts from Abbott Northwestern’s Plus One physician giving program.

    Emergency Department physicians and nurses work with a social worker to ensure that patients have the medications they need to recover at home safely.

  • The Allina Prescription Assistance Program, which successfully assisted 1,273 uninsured patients in 2012—a 7 percent increase over 2011.

    Allina patients saved more than $1 million on medications through the program, which was established to help uninsured patients afford their medications through manufacturer-supported prescription assistance programs, according to Lee Mork, MBA, MS, RPh, director of Pharmacy, Allina Clinic and Community Division.

    "Most of these patients were able to take their prescribed medications that they could not otherwise afford, improving therapeutic outcomes,” said Mork.